This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
Puumala Virus Glycoprotein Polyclonal Antibody
catalog :
PA5-72799
quantity :
100 ug
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
Puumala orthohantavirus
product information
Product Type :
Antibody
Product Name :
Puumala Virus Glycoprotein Polyclonal Antibody
Catalog # :
PA5-72799
Quantity :
100 ug
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Antigen affinity chromatography
Host :
Rabbit
Reactivity :
Virus
Applications :
ELISA: Assay-Dependent
Species :
Virus
Isotype :
IgG
Storage :
Store at 4 C short term. For long term storage, store at -20 C, avoiding freeze/thaw cycles.
Description :
Puumala Virus Glycoprotein are part of the envelope proteins structure of the Puumala virus (PUUV) which is spread by rodents and is transmitted to humans by inhalation or ingestion of food contaminated with rodent excreta (2). Nephropathia epidemica is endemic in western Russia, Finland, Sweden, France, Belgium, Germany, and former Yugoslavia.
Immunogen :
Puumala virus glycoprotein antibody for a 19 amino acid peptide near the amino terminus of the Puumala virus glycoprotein. The immunogen is within amino acids 90 - 140 of Puumala Virus Glycoprotein.
Format :
Liquid
Applications w/Dilutions :
ELISA: Assay-Dependent
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments